+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Human Gene Sequencing Markets, Strategies & Trends - Forecasts by Application, by Technology, by Workflow, by Product, and by Country, with Executive and Consultant Guides - 2023 to 2027

  • PDF Icon

    Report

  • 725 Pages
  • April 2024
  • Region: Global
  • Howe Sound Research
  • ID: 5201286

70,000 Tests are Available Already with More on the Way. Human Gene Sequencing is Taking Off. A Crowded Growing Global Market with Complicated Packaging and Pricing is Emerging with Unlimited Growth Opportunities....

Will all newborns receive genetic testing at birth? What segments are growing fastest? Where are the opportunities now that sequencing has gone mainstream?

Our facts and support = Your success.

The plummeting costs for Genome Sequencing is creating a gold rush. New consumers, new technologies, new market niches. It is reminiscent of the birth of the internet industry; a wide range of well funded players are racing for market share on a global stage. This report forecasts the market size out for five years. The report includes detailed breakouts for 14 countries and 5 regions.

Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities, and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

 

Table of Contents

1 Market Guides
1.1 Human Gene Sequencing Markets - Strategic Situation Analysis & COVID Impact
1.2 Guide for Executives, Marketing, Sales and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors

2 Introduction and Market Definition
2.1 Gene Sequencing Definition In This Report
2.1.1 Gene Sequencing
2.1.2 Hereditary
2.1.3 Non Invasive Prenatal Testing
2.1.4 Oncology
2.1.5 Psychology
2.1.6 WGES
2.1.7 Pharmacogenomic
2.1.8 Direct to Consumer
2.1.9 Research
2.1.10 Other
2.2 The Genomics Revolution
2.3 Market Definition
2.3.1 Revenue Market Size
2.4 Methodology
2.4.1 Methodology
2.4.2 Sources
2.4.3 Authors
2.5 Perspective: Healthcare and the IVD Industry
2.5.1 Global Healthcare Spending
2.5.2 Spending on Diagnostics
2.5.3 Important Role of Insurance for Diagnostics
2.6 Chromosomes, Genes and Epigenetics
2.6.1 Chromosomes
2.6.2 Genes
2.6.3 Epigenetics
2.6.4 Genetic Testing vs. Gene Sequencing
2.6.5 Cost and Pricing Practice

3 Global Listing of Sequencer Installed Base - Location & Contacts
3.1 Notes to Installed Base Listing
3.2 Illumina Installed Base

4 Market Overview
4.1 Players in a Dynamic Market
4.1.1 Academic Research Lab
4.1.2 Diagnostic Test Developer
4.1.3 Instrumentation Supplier
4.1.4 Chemical/Reagent Supplier
4.1.5 Pathology Supplier
4.1.6 Independent Clinical Laboratory
4.1.7 Public National/regional Laboratory
4.1.8 Hospital Laboratory
4.1.9 Physicians Office Lab (POLS)
4.1.10 Audit Body
4.1.11 Certification Body
4.2 Human Gene Sequencing -Markets, Examples and Discussion
4.2.1 Inherited Disease - Not what it used to be
4.2.1.1 Clinical and Research Lines Blur
4.2.1.2 Genetic Counselling - Not so simple anymore
4.2.1.3 The Genetic Blizzard - Issues of Access and Payment
4.2.2 Newborn Screening - The Standard of Care
4.2.2.1 Newborn Screening - Do Parents Want to Know?
4.2.3 NIPT - We’ve Only Just Begun
4.2.3.1 NIPT, IVF and the Fertility Practice - PGS, PGD, CCS
4.2.3.2 NIPT in the Future - Beyond Inherited Disease
4.2.4 Oncology - Understanding Two Worlds
4.2.4.1 The Tumor - A Sequence of Sequencing
4.2.4.2 The Tumor - Biopsy and Liquid Biopsy
4.2.4.3 The Human Genome - Predisposition and Prognosis
4.2.5 Pharmacogenomics
4.2.5.1 Sequencing Not the Only Player
4.2.5.2 New Roles for Old Drugs - A Research Bonanza?
4.2.6 Direct To Consumer - More Than Meets the Eye
4.2.6.1 DTC - How Many Segments?
4.3 Industry Structure
4.3.1 Hospital’s Testing Share
4.3.2 The Rise of the Sequencing Lab
4.3.3 Sequencing as a Commodity
4.3.4 Informatics
4.3.5 Instrument Manufacturer Role
4.3.6 Healthcare Industry Impacts - Still Struggling
4.3.7 Can the Healthcare Industry Adapt?
4.3.8 Genetic Counselling as an Industry
4.3.9 Sequencing Adoption and Cannibalization

5 Market Trends
5.1 Factors Driving Growth
5.1.1 New Diagnoses
5.1.2 Wellness and Prevention
5.1.3 Fertility Technology
5.1.4 Cancer - Screening, Management and Monitoring
5.2 Factors Limiting Growth
5.2.1 Increased Competition Lowers Price
5.2.2 Lower Costs
5.2.3 Healthcare Cost Concerns Curtail Growth
5.2.4 Wellness has a downside
5.3 Sequencing Instrumentation
5.3.1 Instrumentation Tenacity
5.3.2 Declining Cost of Instruments Changes Industry Structure
5.3.3 Long Reads - Further Segmentation
5.3.4 Linked Reads
5.3.5 New Sequencing Technologies

6 Human Gene Sequencing Recent Developments
6.1 Recent Developments - Importance and How to Use This Section
6.1.1 Importance of These Developments
6.1.2 How to Use This Section
6.2 Natera Files Suit Against NeoGenomics
6.3 Genomics England to Sequence 100K Newborns
6.4 Novigenix Raises $14M for NGS based Liquid Biopsy
6.5 LetsGetChecked Launching New PGx Service
6.6 Qiagen, Neuron23 Partner for NGS Diagnostic
6.7 Harbinger Health Technology Focused On Oncogenesis
6.8 Delfi Diagnostics to Develop Early Detection Test
6.9 Dante Labs to Introduce WGS to Italian Healthcare System
6.10 Invitae Neurodevelopmental Disorders Testing Service
6.11 Thermo Fisher Obtains CE Mark for Ion Torrent Genexus
6.12 Myriad Genetics Launches Suite of Cancer Tests
6.13 Oncocyte and Thermo Fisher Strike Partnership Deal
6.14 Illumina Partners With Precision Medicine to Assess Liquid Biopsy
6.15 Sysmex Inostics Develops Ultra-Sensitive Liquid Biopsy
6.16 Twist Bioscience, Centogene Partner on NGS-Based Rare Disease Testing
6.17 Strata Oncology Trial Supports NGS Assay
6.18 NYU Gets FDA Clearance for Sequencing Test
6.19 NeoGenomics to Acquire Inivata
6.20 OncoDNA, Institut Curie Partner on Liquid Biopsy Research
6.21 Cancer Heritability Gene Set Expanded
6.22 Whole-Genome Sequencing Could Replace Cytogenetics
6.23 Twist Bioscience, Berry Genomics Partner on Targeted NGS Assays
6.24 Ancestry Shutters Health Offering
6.25 Genetron Health Targeting Early Cancer Detection
6.26 Pan-European Initiative to Build Tools for Sharing Genomic Data
6.27 UK Government Unveils New Genomic Healthcare Strategy
6.28 Foundation Medicine Liquid Biopsy Gets FDA Approval
6.29 American Heart Association Develops Genetic Testing Guidelines
6.30 Yourgene Health Gets CE Mark for Iona NIPT Test
6.31 NorthShore Looks to Expand Genomics Integration Into Primary Care
6.32 Germline Results From Tumor Sequencing Guides Precision Therapy
6.33 FDA Clears Cancer Genomic Profiling From Personal Genome Diagnostics
6.34 BillionToOne Closes $15M Series A Follow-on Round
6.35 Clinics to Integrate Genomics Into Primary Care

7 Profiles of Key Companies
7.1 10x Genomics, Inc.
7.2 23andME Inc.
7.3 Abbott Laboratories
7.4 AccuraGen Inc.
7.5 Adaptive Biotechnologies
7.6 Admera Health, LLC
7.7 Agilent/Dako
7.8 Akonni Biosystems
7.9 Amoy Diagnostics Co., Ltd.
7.10 Ancestry.com LLC
7.11 Anchor Dx
7.12 Arc Bio
7.13 Arrayit Corporation
7.14 ARUP Laboratories
7.15 Astrid Bio
7.16 Baylor Miraca Genetics Laboratories
7.17 Beckman Coulter Diagnostics
7.18 Becton, Dickinson and Company
7.19 BGI Genomics Co. Ltd
7.20 Bioarray Genetics
7.21 Biocept, Inc.
7.22 Biodesix Inc.
7.23 BioFluidica
7.24 BioGenex
7.25 Biolidics Ltd
7.26 bioMérieux Diagnostics
7.27 Bioneer Corporation
7.28 Bio-Rad Laboratories, Inc.
7.29 Bio-Techne
7.30 C2i Genomics
7.31 Caris Molecular Diagnostics
7.32 CellMax Life
7.33 Centogene
7.34 Cepheid (Danaher)
7.35 Circulogene
7.36 Clinical Genomics
7.37 Color Genomics
7.38 Complete Genomics, Inc. - A BGI Company
7.39 Dante Labs
7.40 Datar Cancer Genetics Limited
7.41 Diasorin S.p.A.
7.42 Element Biosciences
7.43 Epic Sciences
7.44 Epigenomics AG
7.45 Eurofins Scientific
7.46 Excellerate Bioscience
7.47 Fabric Genomics
7.48 Freenome
7.49 FUJIFILM Wako Diagnostics
7.50 Fujirebio
7.51 Fulgent Genetics
7.52 GE Global Research
7.53 Gene by Gene, Ltd.
7.54 Genedrive
7.55 GeneFirst Ltd.
7.56 Genetron Holdings
7.57 Genewiz
7.58 Genomics England
7.59 Genomics Personalized Health (GPH)
7.60 GenomOncology
7.61 Genzyme Corporation
7.62 Grifols
7.63 Guardant Health
7.64 Guardiome
7.65 HeiScreen
7.66 Helix
7.67 Helomics
7.68 Hologic
7.69 HTG Molecular Diagnostics
7.70 Human Longevity, Inc.
7.71 iCellate
7.72 Illumina
7.73 Incell Dx
7.74 Inivata
7.75 Integrated Diagnostics
7.76 Invitae Corporation
7.77 Invivoscribe
7.78 Karius
7.79 Letsgetchecked
7.80 Lexagene
7.81 Lunglife AI Inc
7.82 Macrogen
7.83 MDNA Life SCIENCES, Inc.
7.84 MDx Health
7.85 Medgenome
7.86 Meridian Bioscience
7.87 Mesa Biotech (Thermo Fisher)
7.88 Mesa Laboratories, Inc.
7.89 miR Scientific
7.90 MNG Labs
7.91 NantHealth, Inc.
7.92 Natera
7.93 Nebula Genomics  448
7.94 NeoGenomics
7.95 New England Biolabs, Inc.
7.96 NGeneBio
7.97 Novogene Bioinformatics Technology Co., Ltd.
7.98 Omega Bioservices
7.99 Oncocyte
7.100 OncoDNA
7.101 OpGen
7.102 ORIG3N, Inc.
7.103 Origene Technologies
7.104 Oxford Nanopore Technologies
7.105 Panagene
7.106 Perkin Elmer
7.107 Personal Genome Diagnostics
7.108 Personalis
7.109 Precipio
7.110 PrecisionMed
7.111 Promega
7.112 Protagen Diagnostics
7.113 Qiagen
7.114 QuantuMDx
7.115 Regeneron Pharmaceuticals
7.116 Roche Molecular Diagnostics
7.117 Roswell Biotechnologies
7.118 Seegene
7.119 SeLux Diagnostics
7.120 Sema4 Holdings
7.121 Sequencing.com
7.122 Siemens Healthineers
7.123 simfo GmbH
7.124 Singlera Genomics Inc.
7.125 Singular Genomics
7.126 SkylineDx
7.127 Standard BioTools
7.128 Sure Genomics, Inc.
7.129 Sysmex
7.130 Sysmex Inostics
7.131 Tempus Labs, Inc.
7.132 Thermo Fisher Scientific Inc.
7.133 Ultima Genomics
7.134 Variantyx
7.135 Volition
7.136 Vyant Bio

8 The Global Market for Human Genome Sequencing
8.1 Global Market Overview by Country
8.1.1 Table - Global Market by Country
8.1.2 Chart - Global Market by Country
8.2 Global Market by Application - Overview
8.2.1 Table - Global Market by Application
8.2.2 Chart - Global Market by Application - Base/Final Year Comparison
8.2.3 Chart - Global Market by Application - Base Year
8.2.4 Chart - Global Market by Application - Final Year
8.2.5 Chart - Global Market by Application - Share by Year
8.2.6 Chart - Global Market by Application - Segment Growth
8.3 Global Market by Technology - Overview
8.3.1 Table - Global Market by Technology
8.3.2 Chart - Global Market by Technology - Base/Final Year Comparison
8.3.3 Chart - Global Market by Technology - Base Year
8.3.4 Chart - Global Market by Technology - Final Year
8.3.5 Chart - Global Market by Technology - Share by Year
8.3.6 Chart - Global Market by Technology - Segment Growth
8.4 Global Market by Workflow - Overview
8.4.1 Table - Global Market by Workflow
8.4.2 Chart - Global Market by Workflow - Base/Final Year Comparison
8.4.3 Chart - Global Market by Workflow - Base Year
8.4.4 Chart - Global Market by Workflow - Final Year
8.4.5 Chart - Global Market by Workflow - Share by Year
8.4.6 Chart - Global Market by Workflow - Segment Growth
8.5 Global Market by Product - Overview
8.5.1 Table - Global Market by Product
8.5.2 Chart - Global Market by Product - Base/Final Year Comparison
8.5.3 Chart - Global Market by Product - Base Year
8.5.4 Chart - Global Market by Product - Final Year
8.5.5 Chart - Global Market by Product - Share by Year
8.5.6 Chart - Global Market by Product - Segment Growth

9 Market Sizes by Application
9.1 Hereditary Gene Sequencing Market
9.1.1 Table - Hereditary by Country.
9.1.2 Chart - Hereditary Segment Growth
9.2 NIPT Gene Sequencing Market
9.2.1 Table NIPT by Country
9.2.2 Chart - NIPT Growth
9.3 Oncology Market
9.3.1 Table - Oncology by Country
9.3.2 Chart - Oncology Growth
9.4 Psychology Market
9.4.1 Table - Psychology by Country
9.4.2 Chart - Psychology Growth
9.5 WGES Gene Sequencing Market
9.5.1 Table - WGES by Country
9.5.2 Chart - WGES growth
9.6 Pharmacogenomics Market
9.6.1 Table Pharmacogenomics by Country
9.6.2 Chart - Pharmacogenomics Growth
9.7 DTC Gene Sequencing Market
9.7.1 Table - DTC by Country
9.7.2 Chart - DTC Growth
9.8 Research Gene Sequencing Market
9.8.1 Table - Research by Country
9.8.2 Chart - Research Growth
9.9 Other Application Market
9.9.1 Table - Other Application by Country
9.9.2 Chart - Other Application growth

10 Market Sizes by Technology
10.1 Sanger Sequencing Market
10.1.1 Table - Sanger by Country
10.1.2 Chart - Sanger Segment Growth
10.2 NGS/2G Market
10.2.1 Table NGS/2G  by Country
10.2.2 Chart - NGS/2G  Growth
10.3 3G/Long Market
10.3.1 Table - 3G/Long by Country
10.3.2 Chart - 3G/Long Growth
10.4 Other Technology Market
10.4.1 Table - Other Technology by Country
10.4.2 Chart - Other Technology Growth

11 Market Sizes by Workflow
11.1 Sequencing Market
11.1.1 Table - Sequencing by Country
11.1.2 Chart - Sequencing Segment Growth
11.2 Sample Prep Market
11.2.1 Table Sample Prep by Country
11.2.2 Chart - Sample Prep Growth
11.3 Analysis Market
11.3.1 Table - Analysis by Country
11.3.2 Chart - Analysis Growth

12 Market Sizes by Product
12.1 Instruments Market
12.1.1 Table - Instruments by Country
12.1.2 Chart - Instruments Segment Growth
12.2 Consumables Market
12.2.1 Table Consumables by Country
12.2.2 Chart - Consumables Growth
12.3 Software & Services Market
12.3.1 Table - Software & Services by Country
12.3.2 Chart - Software & Services Growth

13 Vision of the Future of Human Gene Sequencing
14 Appendices
14.1 United States Medicare System: January 2022 Laboratory Fees Schedule
14.2 The Whole Genome Sequence of SARS-CoV-2

List of Tables
Table 1  The Base Pairs
Table 2 Most Common Traditional Genetic Disorders
Table 3 The Base Pairs
Table 4 List of GLOBAL SEQUENCING LOCATIONS
Table 5  Market Players by Type
Table 6 The Different Markets for Human Gene Sequencing
Table 7 DTC Sub Segments
Table 8 The Factors Driving Growth
Table 9 Factors Limiting Growth
Table 10 Six New Sequencing Technologies
Table 11 - Global Market by Region
Table 12 Global Market by Application
Table 13 Global Market by Technology
Table 14 Global Market by Workflow
Table 15 Global Market by Product
Table 16 Hereditary Segment by Country
Table 17 NIPT Segment by Country
Table 18 Oncology Segment by Country
Table 19 Psychology Segment by Country
Table 20 WGES Segment by Country
Table 21 Pharmacogenomics Segment by Country
Table 22 DTC Segment by Country
Table 23 Research Segment by Country
Table 24 Other Application Segment by Country
Table 25 Sanger Segment by Country
Table 26 NGS/2G  Segment by Country
Table 27 3G/Long Segment by Country
Table 28 Other Technology by Country
Table 29 Sequencing Segment by Country
Table 30 Sample Prep Segment by Country
Table 31 Analysis Segment by Country
Table 32 Instruments Segment by Country
Table 33 Consumables Segment by Country
Table 34 Software & Services Segment by Country
Table 35 2022 Clinical Lab Fee Schedule

List of Figures
Figure 1 Global Healthcare Spending
Figure 2 The Lab Test Pie
Figure 3 DNA Strands and Chromosomes
Figure 4 Karyogram of Human Chromosomes
Figure 5 Size of Various Genomes
Figure 6 Global Illumina Installed Base Map
Figure 7 The Road to Diagnostics
Figure 8 TruSight Germline Panel
Figure 9 Historical Cost of Gene Sequencing
Figure 10 - Cost To Sequence a Human Genome
Figure 11 Base Year Country Market Share Chart
Figure 12 Global Market by Application - Base vs. Final Year
Figure 13 Global Market by Application Base Year
Figure 14 Global Market by Application Final Year
Figure 15 Application Type Share by Year
Figure 16 by Application Segment Growth
Figure 17 Global Market by Technology - Base vs. Final Year
Figure 18 Global Market by Technology Base Year
Figure 19 Global Market by Technology Final Year
Figure 20 Technology Type Share by Year  528
Figure 21 by Technology Segment Growth
Figure 22 Global Market by Workflow - Base vs. Final Year
Figure 23 Global Market by Workflow Base Year
Figure 24 Global Market by Workflow Final Year
Figure 25 Workflow Type Share by Year
Figure 26 by Workflow Segment Growth
Figure 27 Global Market by Product - Base vs. Final Year
Figure 28 Global Market by Product Base Year
Figure 29 Global Market by Product Final Year
Figure 30 Product Type Share by Year
Figure 31 by Product Segment Growth
Figure 32 Hereditary vs. Total Market Growth
Figure 33 NIPT vs. Total Market Growth
Figure 34 Oncology vs. Total Market Growth
Figure 35 Psychology vs. Total Market Growth
Figure 36 WGES vs. Total Market Growth
Figure 37 Pharmacogenomics vs. Total Market Growth.
Figure 38 DTC vs. Total Market Growth
Figure 39 Research vs. Total Market Growth
Figure 40 Other Application vs. Total Market Growth
Figure 41 Sanger vs. Total Market Growth
Figure 42 NGS/2G  vs. Total Market Growth
Figure 43 3G/Long vs. Total Market Growth
Figure 44 Other Technology vs. Total Market Growth
Figure 45 Sequencing vs. Total Market Growth
Figure 46 Sample Prep vs. Total Market Growth
Figure 47 Analysis vs. Total Market Growth
Figure 48 Instruments vs. Total Market Growth
Figure 49 Consumables vs. Total Market Growth
Figure 50 Software & Services vs. Total Market Growth

Samples

Loading
LOADING...

Companies Mentioned

  • 10x Genomics, Inc. 
  • 23andME Inc.  
  • Abbott Laboratories 
  • AccuraGen Inc.  
  • Adaptive Biotechnologies  
  • Admera Health, LLC 
  • Agilent/Dako  
  • Akonni Biosystems  
  • Amoy Diagnostics Co., Ltd. 
  • Ancestry.com LLC  
  • Anchor Dx 
  • Arc Bio  
  • Arrayit Corporation   
  • ARUP Laboratories  
  • Astrid Bio  
  • Baylor Miraca Genetics Laboratories 
  • Beckman Coulter Diagnostics  
  • Becton, Dickinson and Company   
  • BGI Genomics Co. Ltd 
  • Bioarray Genetics 
  • Biocept, Inc.   
  • Biodesix Inc.   
  • BioFluidica 
  • BioGenex  
  • Biolidics Ltd  
  • bioMérieux Diagnostics  
  • Bioneer Corporation  
  • Bio-Rad Laboratories, Inc.  
  • Bio-Techne  
  • C2i Genomics  
  • Caris Molecular Diagnostics  
  • CellMax Life   
  • Centogene  
  • Cepheid (Danaher) 
  • Circulogene   
  • Clinical Genomics  
  • Color Genomics  
  • Complete Genomics, Inc. - A BGI Company  
  • Dante Labs  
  • Datar Cancer Genetics Limited 
  • Diasorin S.p.A.  
  • Element Biosciences  
  • Epic Sciences  
  • Epigenomics AG  
  • Eurofins Scientific   
  • Excellerate Bioscience 
  • Fabric Genomics   
  • Freenome   
  • FUJIFILM Wako Diagnostics   
  • Fujirebio 
  • Fulgent Genetics   
  • GE Global Research  
  • Gene by Gene, Ltd. 
  • Genedrive 
  • GeneFirst Ltd.  
  • Genetron Holdings  
  • Genewiz  
  • Genomics England   
  • Genomics Personalized Health (GPH) 
  • GenomOncology 
  • Genzyme Corporation 
  • Grifols 
  • Guardant Health   
  • Guardiome  
  • HeiScreen   
  • Helix  
  • Helomics  
  • Hologic   
  • HTG Molecular Diagnostics 
  • Human Longevity, Inc. 
  • iCellate   
  • Illumina   
  • Incell Dx 
  • Inivata  
  • Integrated Diagnostics  
  • Invitae Corporation   
  • Invivoscribe  
  • Karius 
  • Letsgetchecked  
  • Lexagene   
  • Lunglife AI Inc  
  • Macrogen 
  • MDNA Life SCIENCES, Inc.  
  • MDx Health  
  • Medgenome  
  • Meridian Bioscience 
  • Mesa Biotech (Thermo Fisher) 
  • Mesa Laboratories, Inc.  
  • miR Scientific 
  • MNG Labs 
  • NantHealth, Inc.  
  • Natera  
  • Nebula Genomics  448  
  • NeoGenomics   
  • New England Biolabs, Inc.  
  • NGeneBio   
  • Novogene Bioinformatics Technology Co., Ltd.  
  • Omega Bioservices   
  • Oncocyte   
  • OncoDNA   
  • OpGen  
  • ORIG3N, Inc.   
  • Origene Technologies   
  • Oxford Nanopore Technologies  
  • Panagene 
  • Perkin Elmer  
  • Personal Genome Diagnostics  
  • Personalis  
  • Precipio   
  • PrecisionMed 
  • Promega  
  • Protagen Diagnostics  
  • Qiagen  
  • QuantuMDx  
  • Regeneron Pharmaceuticals   
  • Roche Molecular Diagnostics 
  • Roswell Biotechnologies  
  • Seegene  
  • SeLux Diagnostics 
  • Sema4 Holdings  
  • Sequencing.com   
  • Siemens Healthineers  
  • simfo GmbH  
  • Singlera Genomics Inc.  
  • Singular Genomics  
  • SkylineDx  
  • Standard BioTools 
  • Sure Genomics, Inc. 
  • Sysmex  
  • Sysmex Inostics   
  • Tempus Labs, Inc. 
  • Thermo Fisher Scientific Inc. 
  • Ultima Genomics   
  • Variantyx  
  • Volition  
  • Vyant Bio